Logo image of KRRO

KORRO BIO INC (KRRO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:KRRO - US5009461089 - Common Stock

5.52 USD
-0.21 (-3.66%)
Last: 11/26/2025, 4:36:51 PM
5.54 USD
+0.02 (+0.36%)
After Hours: 11/26/2025, 4:36:51 PM
Fundamental Rating

3

Taking everything into account, KRRO scores 3 out of 10 in our fundamental rating. KRRO was compared to 533 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for KRRO as it has an excellent financial health rating, but there are worries on the profitability. KRRO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year KRRO has reported negative net income.
In the past year KRRO has reported a negative cash flow from operations.
In the past 5 years KRRO always reported negative net income.
In the past 5 years KRRO always reported negative operating cash flow.
KRRO Yearly Net Income VS EBIT VS OCF VS FCFKRRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

KRRO has a Return On Assets of -50.63%. This is comparable to the rest of the industry: KRRO outperforms 48.78% of its industry peers.
Looking at the Return On Equity, with a value of -79.37%, KRRO is in line with its industry, outperforming 54.03% of the companies in the same industry.
Industry RankSector Rank
ROA -50.63%
ROE -79.37%
ROIC N/A
ROA(3y)-50.75%
ROA(5y)-35.9%
ROE(3y)-63.13%
ROE(5y)-44.24%
ROIC(3y)N/A
ROIC(5y)N/A
KRRO Yearly ROA, ROE, ROICKRRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KRRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRRO Yearly Profit, Operating, Gross MarginsKRRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

KRRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KRRO has been increased compared to 1 year ago.
Compared to 5 years ago, KRRO has less shares outstanding
KRRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRRO Yearly Shares OutstandingKRRO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KRRO Yearly Total Debt VS Total AssetsKRRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

KRRO has an Altman-Z score of -3.16. This is a bad value and indicates that KRRO is not financially healthy and even has some risk of bankruptcy.
KRRO has a Altman-Z score (-3.16) which is in line with its industry peers.
KRRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC8.65%
KRRO Yearly LT Debt VS Equity VS FCFKRRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

KRRO has a Current Ratio of 5.98. This indicates that KRRO is financially healthy and has no problem in meeting its short term obligations.
KRRO has a better Current ratio (5.98) than 62.66% of its industry peers.
KRRO has a Quick Ratio of 5.98. This indicates that KRRO is financially healthy and has no problem in meeting its short term obligations.
KRRO's Quick ratio of 5.98 is fine compared to the rest of the industry. KRRO outperforms 64.17% of its industry peers.
Industry RankSector Rank
Current Ratio 5.98
Quick Ratio 5.98
KRRO Yearly Current Assets VS Current LiabilitesKRRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.29% over the past year.
Measured over the past years, KRRO shows a very negative growth in Revenue. The Revenue has been decreasing by -39.89% on average per year.
EPS 1Y (TTM)71.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.04%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-45.55%
Revenue growth 5Y-39.89%
Sales Q2Q%N/A

3.2 Future

KRRO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.89% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-10.2%
EPS Next 2Y-4.16%
EPS Next 3Y-3.96%
EPS Next 5Y1.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KRRO Yearly Revenue VS EstimatesKRRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
KRRO Yearly EPS VS EstimatesKRRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KRRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KRRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRRO Price Earnings VS Forward Price EarningsKRRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRRO Per share dataKRRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

KRRO's earnings are expected to decrease with -3.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.16%
EPS Next 3Y-3.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KORRO BIO INC

NASDAQ:KRRO (11/26/2025, 4:36:51 PM)

After market: 5.54 +0.02 (+0.36%)

5.52

-0.21 (-3.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-16 2026-03-16/amc
Inst Owners96.92%
Inst Owner Change7.66%
Ins Owners0.42%
Ins Owner Change0%
Market Cap51.83M
Revenue(TTM)2.27M
Net Income(TTM)-91.36M
Analysts85.33
Price Target66.3 (1101.09%)
Short Float %13.23%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.74%
Min EPS beat(2)-4.75%
Max EPS beat(2)6.23%
EPS beat(4)3
Avg EPS beat(4)6.81%
Min EPS beat(4)-4.75%
Max EPS beat(4)15.11%
EPS beat(8)6
Avg EPS beat(8)-114.66%
EPS beat(12)9
Avg EPS beat(12)-74.94%
EPS beat(16)10
Avg EPS beat(16)-88.44%
Revenue beat(2)2
Avg Revenue beat(2)288.07%
Min Revenue beat(2)181.42%
Max Revenue beat(2)394.73%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30.76%
PT rev (3m)-29.6%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-5.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)24.89%
Revenue NQ rev (3m)80.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.25
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-9.41
EYN/A
EPS(NY)-10.19
Fwd EYN/A
FCF(TTM)-7.87
FCFYN/A
OCF(TTM)-7.16
OCFYN/A
SpS0.67
BVpS12.26
TBVpS12.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.63%
ROE -79.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.75%
ROA(5y)-35.9%
ROE(3y)-63.13%
ROE(5y)-44.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 144.18%
Cap/Sales 104.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.98
Quick Ratio 5.98
Altman-Z -3.16
F-Score4
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)307.52%
Cap/Depr(5y)347.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.04%
EPS Next Y-10.2%
EPS Next 2Y-4.16%
EPS Next 3Y-3.96%
EPS Next 5Y1.89%
Revenue 1Y (TTM)N/A
Revenue growth 3Y-45.55%
Revenue growth 5Y-39.89%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.59%
OCF growth 3YN/A
OCF growth 5YN/A

KORRO BIO INC / KRRO FAQ

What is the fundamental rating for KRRO stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRRO.


What is the valuation status for KRRO stock?

ChartMill assigns a valuation rating of 0 / 10 to KORRO BIO INC (KRRO). This can be considered as Overvalued.


What is the profitability of KRRO stock?

KORRO BIO INC (KRRO) has a profitability rating of 1 / 10.


What is the financial health of KORRO BIO INC (KRRO) stock?

The financial health rating of KORRO BIO INC (KRRO) is 7 / 10.